Avita Medical, Inc.Avita Medical, Inc.Avita Medical, Inc.

Avita Medical, Inc.

No trades
See on Supercharts

Price target

16.890.000.00%
The 8 analysts offering 1 year price forecasts for RCEL have a max estimate of — and a min estimate of —.

Analyst rating

Based on 8 analysts giving stock ratings to RCEL in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


RCEL EPS for the last quarter is −0.62 USD despite the estimation of −0.43 USD. In the next quarter EPS is expected to reach −0.36 USD. Track more of Avita Medical, Inc. financials and stay on top of what is up with the company.
In the next quarter Avita Medical, Inc. revenue is expected to reach ‪23.20 M‬ USD. Check out Avita Medical, Inc. revenue and earnings and make informed decisions.
According to analysts, RCEL price target is 16.89 USD with a max estimate of 26.34 USD and a min estimate of 10.56 USD. Check if this forecast comes true in a year, meanwhile watch Avita Medical, Inc. stock price chart and keep track of the current situation with RCEL news and stock market news.
We've gathered opinions of 8 analysts rating RCEL stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.